Recent rapid responses
Rapid responses are electronic letters to the editor. They enable our users to debate issues raised in articles published on bmj.com. Although a selection of rapid responses will be included as edited readers' letters in the weekly print issue of the BMJ, their first appearance online means that they are published articles. If you need the url (web address) of an individual response, perhaps for citation purposes, simply click on the response headline and copy the url from the browser window.
Displaying 1-2 out of 2 published
Dear Editor,
We thank Pande and Soumerai for their comments. However, we believe that they present an overly simplistic critique of the study's findings and methodology that is not grounded in the reality of public policy evaluations. First, and most importantly, we did not conclude, as they suggest, that the intervention was ineffective. We were similarly disappointed by reports from some press outlets that suggested otherwise.
The 15% of patrons who reported seeing and using calorie information purchased fewer calories. In 2009, almost 1.3 million New Yorkers reported eating fast food at least once a week , resulting in approximately 3 million visits weekly (1). This means that very substantial numbers of New Yorkers will use this information to purchase fewer calories each week. Furthermore, there were statistically significant declines in the total number of calories purchased in several major chains within the overall restaurant sample.
Since mandatory calorie labeling by restaurant chains has been adopted nationwide in the U.S. and will go into effect next year, and with this expansion the incentive to industry to change its practices grows, we concluded that further rounds of assessment are needed to measure the full impact. It should be noted that the calorie labeling regulation also serves the simple purpose of assuring a consumer's right to know. In that regard, calorie posting was considered useful by 84% of New Yorkers(2). Nevertheless, that information alone will not be sufficient to reverse the obesity epidemic is not a surprise. Rather, it is a challenge for future action.
Pande and Soumerai's initial point suggests that evaluation of calorie posting in New York City could be meaningfully pursued only with Cochrane-quality randomized trials. While this may represent a scientific ideal, the restaurant industry, which aggressively opposed the policy through the courts, would simply not have cooperated with randomization. Randomized trials have not been feasible for key public health policies such as those that required seatbelts, raised tobacco taxes or removed lead from paint. While using other jurisdictions as controls is a reasonable alternative suggestion, it was not feasible within the narrow timeframe of a few months between approval and implementation. New York City rapidly designed and funded this study to ensure a large and representative sample of affected fast food chains and their customers. We agree with Pande and Soumerai that the study has important limitations, which were clearly discussed in the publication. However, the presence of these limitations does not obviate our findings and, as with all publications, serves to inform the reader as to how the results should and should not be interpreted.
Unfortunately, no other jurisdiction, subsequent to the implementation of this measure, has been able to carry out even a similarly scaled evaluation. This reflects the typical difficulties confronting policy evaluation, where timely studies are often the only option, and while imperfect, still furnish critically useful information. We welcome other studies with different designs that complement our work, particularly if baseline measures of sufficiently representative samples can be taken before a calorie labeling policy goes into effect elsewhere.
In regard to Pande and Soumerai's concern about contamination of the baseline data, the information previously provided by Subway at baseline was restricted to a small sticker on the display case and provided calorie values for only a few of their products. Thus it was not equivalent to earlier implementation of comprehensive calorie posting. More importantly, the evaluation of a public policy, which was ultimately the goal of the study, is to measure what changes occur in society with its implementation. If one company voluntarily provided some information at baseline, that was, in fact, the societal condition prior to the policy and hence does not invalidate our findings.
It seems obvious, but perhaps merits note, that the food industry is well positioned to assess the impact of calorie labeling upon its sales through its cash register data. However, with the exception of the Starbucks chain, which supported a large study whose results showed a 6% decline in calories purchased without loss of revenue at their establishments,(3) no other company has chosen to share its sales data.
We welcome discussion and debate on how to assure the evaluation of public policy innovations, and believe there is an urgent need for funding pools designed to support the assessment of innovative public health policies within typical fast moving timeframes. As nations, we need a bigger commitment to the evaluation of large scale public health measures with the potential to change population health status.
Lynn Silver MD, MPH, FAAP
Mary T. Bassett, MD, MPH
(1) New York City Community Health 2009, Unpublished data.
(2) Quinnipiac University Polling Institute. New Yorkers big on sugar drink tax, calorie counts 2011. www.quinnipiac.edu/x1302.xml?ReleaseID=1425
(3) Bollinger B, Leslie P, Sorenson A. calorie posting in chain restaurants. The National Bureau of Economic Research, Working paper no. 15648. 2010. Nber.org/papers/w15648
Competing interests: None declared
New York City Department of Health and Mental Hygiene
The paper by Dumansovsky et al in the 26th July issue of BMJ addresses an important question on the effect of calorie labeling in restaurants. However, it uses one of the weakest research designs (uncontrolled pre-post study) that would not merit inclusion in a Cochrane Systematic Review of health systems. This un-interpretable paper has received widespread publicity and is being presented as a causal argument against labeling food in restaurant menus (e.g., Wall Street Journal, Economist, Time Magazine). To be sure, calorie labeling may have no effect. However, due to serious methodological flaws, this study cannot contribute to this debate.
First, the uncontrolled design does not account for a variety of factors that may explain the observed finding of no change, before and after the law. For example, availability and advertising of cheap high calorific foods from 2007 to 2009 could have resulted in an overall increase in calorie consumption in other cities. The fact that there is no difference in calorie consumption in New York City between 2007 and 2009 could actually be misinterpreted. This is unfortunate as the study could have easily integrated a control group by collecting data during the same time period from other cities, preferably bordering New York City with similar population characteristics but no labeling law.
Second, the "before" group ( a single time point) is not an appropriate group for comparison as some restaurants surveyed in 2007 already had calorie labeled their food. The authors mention that the Subway chain labeled their menu for some foods in 2007. This would contaminate any comparison of the effect of labeling on caloric intake and bias the results towards the null or no effect of the law.
Given the importance of this topic for the national debate on interventions to control obesity, the study could result in more harm than good. As academics focusing in study design, we feel that this study should not have been published in such a prestigious journal.
Aakanksha H. Pande, MS Stephen B. Soumerai, Sc. D. Department of Population Medicine, Harvard Medical School & Harvard Pilgrim Health Care Institute, Boston, MA. July 28th, 2011. apande@fas.harvard.edu
Competing interests: None declared
Harvard Medical School & Harvard Health Pilgrim Health Care Institute








Re: Restoring invisible and abandoned trials: a call for people to publish the findings
Published 19 June 2013
Re: Austerity policies in Europe—bad for health
Published 19 June 2013
Re: The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers
Published 19 June 2013
Is there a role for agents affecting the GLP-1 system in treatment of type 2 diabetes today? No!
Published 19 June 2013